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Isochromosome 5p-i(5)(p10)-represents a rare but recurrent abnormality in myeloid disorders,
especially in acute myeloid leukemia. In all published cases, the isochromosome 5p was present in
single copy and accompanied by one or more additional anomalies, mostly trisomy 8. Here we report a
case of refractory cytopenia with multilineage dysplasia with two copies of isochromosome 5p, a single
normal chromosome 5 and an apparently balanced translocation between long arms of chromosome
7 and 10. To our knowledge, the pentasomia 5p has never been described before the present study.
& 2013 Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
Loss of material from chromosome arm 5q is a common
abnormality in myelodysplastic syndrome (MDS) and, if it is the
only one, it’s recognized as a distinct pathological entity (‘‘iso-
lated 5q- syndrome’’) with good prognosis.
In contrast, gain of material from chromosome 5 is a rare
event; the formation of an isochromosome of the short arm –
i(5)(p10) – has been described in a very few cases of MDS and in
about ten patients with acute myeloid leukemia (AML). The
formation of i(5)(p10) results from the loss of the long arm of
chromosome 5 and duplication of its short arm.
In literature, two types of i(5)(p10) are observed 1:1) i(5)(p10) inducing a loss of the long arm of the chromosome
(monosomy 5q and trisomy of the short arm): þ39 0315859829.
. Giudici),
-NC-ND license.2) a supernumerary i(5)(p10), in addition to two normal chro-
mosomal 5, resulting in a tetrasomy of the short arm.
Here we report a MDS case with two copies of isochromosome
5p and a single normal chromosome 5. To our knowledge, the
pentasomia 5p has never been described before the present study.2. Materials and methods
2.1. Patient
In 2008, a 69-year-old man, who presented isolated thrombo-
cytemia without immunological basis for several years (Hb
13.6 g/dL; WBC 8.930/mm3; PLT 49.000/mm3), was submitted to
bone marrow aspiration. Diagnosis was consistent with myelo-
dysplastic syndrome: sample showed erythrocytic hyperplasia
with dyserythropoiesis and a normal number of megakaryocytes,
mostly of small size.
On account of abnormal liver and iron metabolism parameters,
molecular analysis of HFE gene was performed, resulting in
diagnosis of hereditary hemochromatosis (compound heterozy-
gote H63D/C282Y).
In June 2012, the patient, in addition to chronic thrombocyto-
penia, developed ingravescent anemia (Hb 8.3 g/dL). A new
cytomorphological analysis of bone marrow aspiration was
Fig. 1. Karyotype of the patient:.47, XY, i(5)(p10), þ i(5)(p10), t(7;10)(q35;q22).
Fig. 2. FISH on metaphase with loci speciﬁc probes for 5p15 (green) and 5q31
(red). The arrows point at the two isochromosomes 5p. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version
of this article.)
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biopsy allowed classiﬁcation as ‘‘refractory cytopenia with multi-
lineage dysplasia’’ (RCMD), without excess of blasts (WHO 2008);
no peculiar morphophenotypical feature was observed.
In September 2012 his clinical conditions worsened dramati-
cally, with these parameters of pancytopenia: Hb 5.3 g/dL; WBC
1.990/mm3; PLT 8.000/mm3.
2.2. Cytogenetic study
In June 2012 cytogenetic studies were performed on unstimu-
lated peripheral blood and bone marrow cells, after 24 and 48 h
cultures.
Chromosomes were identiﬁed using standard Q-banding techni-
ques and the karyotype was described according to the International
System of Human Cytogenetic Nomenclature (ISCN 2009) Fig. 1.
2.3. FISH
The isochromosomes 5p were conﬁrmed by ﬂuorescence
in situ hybridization (FISH) using a speciﬁc probe for 5p15 labeled
with FITC; a probe for EGR1 locus on 5q31 labeled with Texas Red
was co-hybridized (Cytocell, Cambridge, UK) Fig. 2. Moreover,metaphases were tested using whole chromosome painting probe
of chromosome 5 (wcp 5)(Cytocell) and a locus-speciﬁc probe for
7q22.1 (FITC) and 7q31 (Texas Red) (Cytocell).3. Results
Thirty metaphases from bone marrow cultures were studied
and the karyotype was
47,XY,i(5)(p10),+i(5)(p10),t(7;10)(q35,q32)[12]/47,XY,i(5)(p10),
+i(5)(p10)[8]/46,XY[10].
In summary, the analysis revealed only one normal chromo-
some 5 and two copies of isochromosome 5p, resulting in a
pentasomia 5p and monosomia 5q. An additional aberration was
associated in 12/20 abnormal metaphases: an apparently
balanced translocation between long arms of chromosomes
7 and 10. Derivative chromosome 7 was conﬁrmed by FISH.
Peripheral blood cell analysis showed only few metaphases
and the same clonal abnormalities were found.4. Discussion
To date, an i(5)(p10) has been found in a very small number of
patients (10 AML, 4 MDS, one secondary MDS after treatment of a
multiple myeloma).2–5 In particular, among MDS patients there
were one case of refractory cytopenia with multilineage dysplasia
and another one of refractory anemia with ringed sideroblasts.2
In all published cases, the i(5)(p10) was present in single copy
and accompanied by one or more additional anomalies, mostly
trisomy 8. The biological and clinical signiﬁcance is yet unclear,
not only because too few cases have been described, but also
because these aberrations usually occur within a complex kar-
yotype, in itself with poor prognosis.
To our knowledge, this is the ﬁrst reported case of hematolo-
gical disorder to show clones with two copies of i(5)(p10).
Though our patient received a diagnosis of MDS in 2008, he
remained without any treatment, but for a periodical adminis-
tration of prednisone due to thrombocytopenia. In addition, he
has recently developed severe pancytopenia and he needs blood
transfusions.
Unfortunately, no cytogenetic analysis was performed at the
onset of disease; therefore we cannot establish whether the
i(5)(p10) aberration represents a driving change or rather a
progression event.
Interestingly, our patient is affected by inherited hemochroma-
tosis (compound heterozygote H63D/C282Y), genetic defect lead-
ing to uncontrolled iron deposition, mostly in parenchymal organs.
Recent studies have displayed a non random relationship
between C282Y and H63D mutations of hemochromatosis gene
and myelodysplasia, suggesting a possible role of iron overload in
pathogenesis of myelodysplastic disorders. 6,7
The common transfusion-dependence of MDS patients may
also contribute to increase hemosiderosis, as in a vicious circle,
and an early administration of iron-chelating agents should be
taken in consideration.
In agreement with former studies, we emphasize the relevance
of using speciﬁc probes of chromosome 5p/5q as a necessary
complement of conventional karyotype, because an isochromo-
some 5p may lead to a wrong conclusion of metacentric del(5q), a
much more common ﬁnding.
In conclusion, i(5)(p10) is a rare but recurrent abnormality in
myeloid disorders, especially in AML. Although the bone marrow
biopsy of our patient didn’t show excess of blasts, cytogenetic
ﬁndings of two copies of isochromosomes 5p and an additional
translocation deserve a close follow up.
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